Edition:
United States

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

5.20USD
1:50pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.20
Open
$5.19
Day's High
$5.23
Day's Low
$5.19
Volume
1,710
Avg. Vol
4,959
52-wk High
$11.99
52-wk Low
$4.93

Latest Key Developments (Source: Significant Developments)

Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results
Wednesday, 28 Mar 2018 07:00am EDT 

March 28 (Reuters) - Alpine Immune Sciences Inc ::ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS.ALPINE IMMUNE SCIENCES - EXPECTS TO HAVE CASH TO FUND OPERATIONS INTO 2020, INCLUDING CLINICAL ADVANCEMENT OF ITS LEAD PROGRAMS ALPN-101 AND ALPN-202.  Full Article

Alpine Immune Sciences qtrly earnings per share ‍$0.18​
Monday, 13 Nov 2017 04:05pm EST 

Nov 13 (Reuters) - Alpine Immune Sciences Inc ::Alpine Immune Sciences reports corporate update and third quarter 2017 financial results.Q3 revenue $100,000 versus $700,000.Alpine Immune Sciences Inc - ‍company expects to have cash to fund operations into 2020​.Alpine Immune Sciences Inc qtrly earnings per share ‍$0.18​.  Full Article

BRIEF-Alpine Immune Sciences Qtrly Loss Per Share $0.38

* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS